Your browser doesn't support javascript.
loading
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma, Qinhai; Li, Runfeng; Pan, Weiqi; Huang, Wenbo; Liu, Bin; Xie, Yuqi; Wang, Zhoulang; Li, Chufang; Jiang, Haiming; Huang, Jicheng; Shi, Yongxia; Dai, Jun; Zheng, Kui; Li, Xiaobo; Hui, Min; Fu, Li; Yang, Zifeng.
Afiliação
  • Ma Q; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Li R; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Pan W; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Huang W; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Liu B; Kunming University of Science and Technology Library, Kunming, China.
  • Xie Y; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Wang Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Li C; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Jiang H; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Huang J; Technology Centre, Guangzhou Customs, Guangzhou, China.
  • Shi Y; Technology Centre, Guangzhou Customs, Guangzhou, China.
  • Dai J; Technology Centre, Guangzhou Customs, Guangzhou, China.
  • Zheng K; Technology Centre, Guangzhou Customs, Guangzhou, China.
  • Li X; Technology Centre, Guangzhou Customs, Guangzhou, China.
  • Hui M; Jilin Yatai Chinese Medicine Development Institute, Changchun, Jilin, China.
  • Fu L; Jilin Yatai Chinese Medicine Development Institute, Changchun, Jilin, China.
  • Yang Z; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China; State Key Laboratory of Quality Research in Chinese Medicine,
Phytomedicine ; 78: 153296, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32890913
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Antivirais / Pneumonia Viral / NF-kappa B / Infecções por Coronavirus / Coronavirus Humano 229E / Pandemias / Betacoronavirus / Glucosídeos / Anti-Inflamatórios Idioma: En Revista: Phytomedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Antivirais / Pneumonia Viral / NF-kappa B / Infecções por Coronavirus / Coronavirus Humano 229E / Pandemias / Betacoronavirus / Glucosídeos / Anti-Inflamatórios Idioma: En Revista: Phytomedicine Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China